
Sutykine 25mg Capsule
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Sunitinib (25mg)
Overview Sutykine 25mg Capsule
Sutent 25mg capsules treat kidney cancer and gastrointestinal stromal tumors by inhibiting enzymes that fuel cancer cell growth, thus reducing tumor size and slowing progression. This medication can be ingested with or without food, but consistent daily timing optimizes efficacy. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Strict adherence to your doctor's instructions is crucial; improper usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include fatigue, diarrhea, nausea, vomiting, altered taste, and reduced appetite. Regular blood pressure and thyroid function monitoring may be recommended. Sutent can lower blood glucose, potentially causing hypoglycemia and fainting; diabetics should closely monitor their blood sugar and discuss potential anti-diabetic medication adjustments with their doctor. Prior to commencing treatment, inform your doctor of any pre-existing heart, liver, kidney, or bleeding disorders. Inform your healthcare provider of all other medications you are taking due to potential interactions. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception for both partners is essential throughout treatment.
Uses of Sutykine 25mg Capsule
Managing renal cell carcinoma and gastrointestinal stromal tumors.
Major Benefits of Sutykine 25mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Sutykine 25mg Capsules. These capsules can be ingested with or without food, although consistent timing is recommended.
Common Side effects of Sutykine 25mg Capsule:
- Hand-foot syndrome
- Bleeding disorder
- Low blood platelets
- Decreased appetite
- Nausea
- Vomiting
- Weakness
- Abdominal pain
- Indigestion
- High blood pressure
- Diarrhea
- Stomatitis (Inflammation of the mouth)
- Taste change
How to use Sutykine 25mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Sutykine 25mg Capsules. These capsules can be consumed with or without food, though consistent timing is recommended.
How Sutykine 25mg Capsule works:
Sutykine 25mg capsules are an anticancer drug that inhibits the activity of specific tyrosine kinase proteins on cell surfaces, thus hindering cancer cell multiplication. The medication also limits the development of new blood vessels supplying the tumor, thereby suppressing malignant growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of alcohol consumption while taking a 25mg Sutykine capsule is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Sutykine 25mg Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Sutykine 25mg Capsules while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Sutykine 25mg Capsules, which can induce dizziness. Refrain from driving or operating machinery if dizziness occurs during treatment.
KidneySAFE IF PRESCRIBED
Sutykine 25mg capsules can be administered to patients with renal impairment without modification of the prescribed dosage.
LiverSAFE IF PRESCRIBED
Sutykine 25mg capsules can be administered to patients with hepatic impairment without requiring a modification of the prescribed dosage.
What if you forget to take Sutykine 25mg Capsule :
Should you forget a Sutykine 25mg Capsule dose, omit that dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Sutykine 25mg Capsule
| Label | Value |
|---|---|
| Chemical Type | Indole and Pyrrole Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
